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Infective Endocarditis Chemoprophylaxis for Adults: New Guidelines
KELVIN KAI-WANG TO,1 CHU-PAK LAU,2 CYRUS-RUSTAM KUMANA2
From 1Department of Microbiology, Queen Mary Hospital; 2Department of Medicine, The University of Hong Kong,
Queen Mary Hospital, Hong Kong SAR
TO ET AL.: Infective Endocarditis Chemoprophylaxis for Adults: New Guidelines. The concept of infective
endocarditis chemoprophylaxis has undergone dramatic changes in recent few years, as exemplified by the latest
guidelines from the British Society for Antimicrobial Chemotherapy (BSAC) and the American Heart Association
(AHA). Although there are minor differences between the two, both guidelines agree that having a dental procedure
is not an important risk factor and that chemoprophylaxis is not required except for patients at high risk if they
develop infective endocarditis. It is important for cardiologists, dentists and other health care professionals to aware
of this change in order not to overprescribe antimicrobial prophylaxis. (J HK Coll Cardiol 2008;16:1-4)
Infective endocarditis, new chemoprophylaxis guidelines

Infective endocarditis (IE) is associated with
significant morbidity and mortality. Traditionally, we
were taught that for patients at increased risk of infective
endocarditis (such as those with structural cardiac
defects, including prosthetic valves), antibiotic
prophylaxis was a requirement to cover dental
procedures. This practice was based on the belief that
high grade bacteraemia resulting from such procedures
could give rise to IE and that bactericidal antibiotic
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concentrations in the blood at the relevant time could
prevent this complication. Owing to the rarity of IE,
clinical trial evidence for such interventions was always
lacking. Nevertheless chemoprophylaxis guidelines for
IE became enshrined in medical folklore, possibly
driven by medicolegal considerations. Both British and
American authorities therefore started to issue
consensus IE chemoprophylaxis guidelines, to cover
dental as well as other potentially bactericidal
procedures (Table 1), and these were updated at intervals
of 3-4 years. However, the most recent guidelines
published by the British Society for Antimicrobial
Chemotherapy (BSAC) 1 and the American Heart
Association (AHA)2 have challenged our traditional
practices, particularly with respect to dentistry (Tables
2-5).
The pathogenesis of IE has been well described
elsewhere.3 Briefly, turbulent flow created by structural
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Table 1. Traditional risk factors warranting chemoprophylaxis against infective endocarditis
Moderate risk

Congenital heart & great vessel abnormalities (not for uncomplicated atrial septal defect or ligated
patent ductus arteriosus)
Heart valve abnormality (especially regurgitation)

High risk

MV prolapse with regurgitation
Prosthetic (tissue or synthetic) heart valve
Implanted AV or VA shunt
Previous infective endocarditis

Table 2. According to latest guidelines, only the following high risk groups warrant prophylaxis
BSAC guideline 2006 Previous infective endocarditis
Cardiac valve replacement surgery
Surgically constructed systemic or pulmonary shunt or conduit
AHA guideline 2007 Prosthetic cardiac valve
Previous infective endocarditis
Congenital heart disease (CHD)
Unrepaired cyanotic CHD, including palliative shunts and conduits
Completely repaired congenital heart defect with prosthetic material or device, whether placed by
surgery or by catheter intervention, during the first 6 months after the procedure
Repaired CHD with residual defects at the site or adjacent to the site of a prosthetic patch or prosthetic device
Cardiac transplantation recipients who develop cardiac valvulopathy

lesions damages the endothelium. Deposition of platelet
and fibrin results in the formation of nonbacterial
thrombotic endocarditis. Bacteria, which may be present
in blood after every day activity (chewing, defaecation)
or invasive procedures, can adhere to such traumatized
sites and proliferate to form a vegetation.
Since antibiotic prophylaxis can reduce the
magnitude of such bacteraemias, theoretically it could
also reduce the incidence of IE. Moreover, animal
experiments confirm that used in this way, antibiotics
reduce the risk of developing endocarditis on damaged
valves.4,5 Yet extrapolation of such animal data to man
warrants caution, for a number of reasons. First, the
bacterial inoculums used in these experiments (106-108
CFU/ml) far exceeded those resulting from dental and
other procedures (<104 CFU/ml). Second, patients with
periodontitis actually produce bacteraemia of similar
magnitude to those ensuing after tooth brushing,

2

chewing and scaling. 6 In the same study, healthy
controls (without periodontitis) were found to have
a much lower chance of detectable bacteraemia after
similar every day activities, indicating that good oral
hygiene is paramount in reducing the extent of
transient bacteraemia. It has been estimated that the
cumulative exposure to such every day bacteraemia
may be as high as 5-6 million times greater than after
a single tooth extraction.7 Both British and American
opinion leaders have therefore concluded that the risk
from an individual dental procedure is minimal,
compared to the cumulative risk of random
bacteraemias from daily activities, (brushing the teeth
and chewing). Third, with regard to clinical studies,
it must be conceded that the results from case control
studies were inconsistent. 8,9 Finally, it appears that
the risk of serious adverse effects from taking
antibiotics could well outweigh the risk of IE after
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Table 3. Adult − Dental procedures*
Standard regimen (oral)

Special situation (oral)
Allergic to penicillin or ampicillin
Recent use of amoxicillin or ampicillin

BSAC guideline 2006
Amoxicillin 3 g po 1 hour before
procedure

AHA guideline 2007
Amoxicillin 2 g po given 30-60 min
before procedure

Clindamycin 600 mg po 1 hour
before procedure

Cephalexin 2 g po or Clindamycin
600 mg po or Azithromycin or
clarithromycin 500 mg po given 30-60 min
before procedure

If unable to swallow capsules:
Azithromycin 500 mg po 1 hour
before procedure

(Cephalosporins should not be used in an
individual with a history of anaphylaxis,
angioedema or urticaria with penicillins or
ampicillin)

Standard regimen (IV)

Amoxicillin 1 g IV just before
procedure or at induction of
anaesthesia

Ampicillin 2 g IM/IV or Cefazolin or
Ceftriaxone 1g IM/IV given 30-60 min
before procedure

Special situation (IV)
Allergic to penicillin or ampicillin
Recent use of amoxicillin or ampicillin

Clindamycin 300 mg IV
just before procedure or at
induction of anaesthesia

Cefazolin 1g IM/IV or Ceftriaxone 1 g
IM/IV or Clindamycin 600 mg IM/IV
30-60 min before procedure
(Cephalosporins should not be used in an
individual with a history of anaphylaxis,
angioedema or urticaria with penicillins or
ampicillin)

*All dental procedures that involve manipulation of gingival tissue or the periapical region of teeth or perforation of the oral mucosa

Table 4. Adult − Genitourinary, gastrointestinal, respiratory or obstetrics/gynaecology procedures*
General
Allergic to penicillin

BSAC guideline 2006
Amoxicillin 1 g IV + Gentamicin 1.5 mg/kg IV given just before
the procedure or at induction of anaesthesia
Teicoplanin 400 mg IV + Gentamicin 1.5 mg/kg IV given just
before the procedure or at induction of anaesthesia

AHA guideline 2007
Not required

*Cystoscopy, urethral dilatation, transurethral prostatic resection, transrectal prostatic biopsy, vaginal hysterectomy, Caesarian section

Table 5. Adult − Nasal packing or nasal intubation
General
Allergic to penicillin
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BSAC guideline 2006
Flucloxacillin 1 g IV given just before the
procedure or at induction of anaesthesia
Clindamycin 600 mg IV given just before the
procedure or at induction of anaesthesia
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AHA guideline 2007
Not required
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dental procedures; the risk of a fatal anaphylactic
reaction may be as high as 1 in 40,000.10
Thus, it is now agreed that antibiotics
prophylaxis is only indicated in those who are at
highest risk if they develop IE, in which case potential
benefits may outweigh the risks. Moreover, by
eliminating the moderate risk group, antibiotics
regimens are much simpler.
Fo r n o n - d e n t a l p r o c e d u r e s , i n c l u d i n g
gastrointestinal (GI) and genitourinary (GU)
procedures, the AHA has abolished antibiotic
prophylaxis altogether for all patients, including those
at highest risk. Although these procedures may be
associated with transient enterococcal bacteraemia,
the evidence for a link between GI or GU tract
manoeuvres and IE is weak, and there are no studies
demonstrating that such measures were likely to be
efficacious. By contrast, the BSAC has taken a more
cautionary approach to the lack of evidence, and
decided to retain antibiotic prophylaxis for both the
moderate and high risk patients.
The latest guidelines are by no means gold
standards, since there has never been a randomized
controlled trial of outcome to address these issues.
Indeed, British Guidelines published by different
authorities are inconsistent. For example, in the
September 2007 issue of the British National
Formulary, the moderate risk group is retained.11 At
the other extreme, the guideline published by NICE
in March 2008 has proposed abolishing antibiotic
prophylaxis for IE, even for the high risk group.12
We believe that the changes in both the latest
AHA and BSAC guidelines provide practical advice
for patients undergoing dentistry. For all complex
cases, expert opinion should be sought.
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